Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07048496

Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University of Pennsylvania · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The proposed project will have two separate cohorts. The first will be to perform a more in-depth qualitative assessment of the barriers and facilitators for treatment compliance for non-muscle invasive bladder cancer. The second arm will be to create and test a BCG at home program. Participants in the second cohort will be enrolled in a conversational agent to measure patient symptoms and quality of life and improve self-efficacy.

Detailed description

The proposed project will have two separate cohorts. The first will be to perform a more in-depth qualitative assessment of the barriers and facilitators for treatment compliance for non-muscle invasive bladder cancer. The second arm will be to create and test a BCG at home program. Participants in the second cohort will be enrolled in a conversational agent to measure patient symptoms and quality of life and improve self-efficacy.

Conditions

Interventions

TypeNameDescription
OTHERBCG delivery at homeThe BCG at home project will be a single-arm prospective pilot, to evaluate the feasibility, scalability and effectiveness of home treatment, and utilize the BB-Bot (chatbot) for PRO and adverse event measurement.

Timeline

Start date
2025-07-05
Primary completion
2026-08-05
Completion
2026-09-05
First posted
2025-07-02
Last updated
2025-08-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT07048496. Inclusion in this directory is not an endorsement.